ONTO Health Acquires LEVY Health to Expand Fertility and Longevity Care
ONTO Health has acquired LEVY Health, a clinical decision support company specializing in precision diagnostics and patient intake for reproductive medicine, announced in a press release. The acquisition follows ONTO Health’s $20 million Series A funding and supports the company’s expansion across the United States and into the Gulf Cooperation Council region.
LEVY Health’s software infrastructure will become the technological foundation for ONTO Health’s fertility and longevity care network. The integration will allow clinics to identify endocrine disorders more efficiently and streamline fertility workups.
ONTO Health, founded by Dr. Roohi Jeelani, is advancing its use of AI to assist clinical decision-making in diagnostics, automation, and individualized care. LEVY Health’s co-founder and CEO Caroline Mitterdorfer said the partnership will extend their tools to a broader network of clinicians and patients, enabling more precise and accessible fertility services.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 Intuit Agrees to Acquire AI Billing Startup Sequence for Reported $200 Million Oct 16 Matters Raises $5 Million to Build AI Consumer Bank Oct 16 KP Labs raises €4.42 million for AI data processing in orbit Oct 15 Origin Raises $20 Million for Autonomous Construction Robots Oct 15 Symbe Raises $5.7 Million for AI Sales PlatformMore from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsAI Funding Brief
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Healthleap Raises $38 Million for Hospital Risk Screening AI
Linearis Joins Two Canadian AI Health Data Projects
SENA Health Raises Series A for AI Care Coordination
Ayble Health Raises $16 Million for Virtual Digestive Care
Oracle Health Plans AI Tools for Revenue Cycle Management
Daily AI Brief: the AI news that matters, in your inbox.